Co-Authors
This is a "connection" page, showing publications co-authored by Fuchun Zhang and Linghua Li.
Connection Strength
0.276
-
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18; 1(1):105-113.e4.
Score: 0.221
-
Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa187.
Score: 0.055